ConductScience.org, home
Genes
API referenceFor AI assistants

Gene · 442909

MIR342: microRNA 342

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. MIR342: microRNA 342. Genes, record 442909. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/442909

On this page

Gene

Symbol
MIR342
HGNC
Name
microRNA 342
HGNC
NCBI Gene ID
442909
NCBI Gene
HGNC ID
HGNC:31778
HGNC
Ensembl
ENSG00000199082
NCBI Gene
Aliases
MIRN342, hsa-mir-342
NCBI Gene
Type
ncRNA
NCBI Gene

Proteins0

Reviewed human proteins whose Swiss-Prot entry states the gene.

None in this release.

Patents0

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

None in this release.

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants609

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleMIR342 papersNewest fiscal year
P30CA016058Cancer Center Support Grant52025
P30CA016672Cancer Center Support Grant52025
P30CA014089University of Southern California Norris Comprehensive Cancer Center Support Grant (CCSG)32025
P30CA016056Roswell Park Cancer Center Support Grant32025
IK6BX004016BLRD Research Career Scientist Award Application22025
K12CA090625Vanderbilt Clinical Oncology Research Career Development Award22025
P30AG028740University of Florida Older Americans Independence Center (OAIC)22025
P30CA051008Georgetown University Lombardi Comprehensive Cancer Center Support Grant22025
P30DK079626UAB Diabetes Research Center22025
P30ES017885Michigan Center on Lifestage Environmental Exposures and Disease (M-LEEaD)22025

1 to 10 of 609Source NIH's project files

See all 609 nih grants

Papers1,597

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
RETRACTION: MicroRNA-342 Promotes the Malignant-Like Phenotype of Endometrial Stromal Cells via Regulation of Annexin A2.Anal Cell Pathol (Amst)202642781897PubTator, text miningPubMed
Metastasis of triple negative breast cancer is regulated by a targetable miR-342-E2F network.EMBO Mol Med202642629473PubTator, text miningPubMed
Consolidating Clinical Insights and Uncovering Novel Regulatory Mechanisms of Exosomal MicroRNAs in Obesity and Metabolic Dysfunction Associated Steatotic Liver Disease: A Systematic Review and Bioinformatics Analysis.
Food Sci Nutr202642254426PubTator, text miningPubMed
Exosomes in diabetic kidney disease: pathogenesis, biomarker discovery, and emerging therapeutics-a comprehensive systematic review.Ren Fail202641845912PubTator, text miningPubMed
Diagnostic Potential of Circulating miRNAs in Glioma: A Systematic Review and Meta-Analysis.Int J Mol Sci202641751817PubTator, text miningPubMed
Diet-Driven Epigenetic Alterations in Colorectal Cancer: From DNA Methylation and microRNA Expression to Liquid Biopsy Readouts.Biomedicines202641751166PubTator, text miningPubMed
The relationship between serum levels of miR-342 and miR-148a and acute lung injury in sepsis patients.Open Med (Wars)202641726132PubTator, text miningPubMed
miRNA gene mutations commonly disrupt the proper functioning of miRNA genes.Sci Adv202641706844PubTator, text miningPubMed
The Expression and Potential Role of MicroRNAs in Oral Lichen Planus.J Oral Pathol Med202641635022PubTator, text miningPubMed
Role of tumor‑infiltrating lymphocytes and miR‑155 in breast cancer: Insights into carcinogenesis and their potential as prognostic biomarkers (Review).Oncol Rep202641543151PubTator, text miningPubMed

1 to 10 of 1,597

See all 1,597 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/442909

GET https://conductscience.org/api/genes/v1/442909/grants?page=2

API referenceFor AI assistants